Dan Becker is a physician, scientist, and biopharma investor currently serving as Managing Director at Access Biotechnology since 2019. They hold board member positions at several companies, including Day One Biopharmaceuticals and Mariana Oncology. Dan’s past experience includes a pivotal role as a Board Member at Pandion Therapeutics, which was acquired by Merck for $1.85 billion. Educated at the University of Michigan Medical School, Dan obtained an MD with distinction and is also pursuing a PhD in Cellular and Molecular Biology.
This person is not in any teams
This person is not in any offices